| 1 |
29370077 | p53 Gene (NY-CO-13) Levels in Patients with Chronic Myeloid Leukemia: The Role of Imatinib and Nilotinib. | 2018 Jan 25 |
3 |
| 2 |
29483845 | MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia. | 2018 |
1 |
| 3 |
24968304 | Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia. | 2014 |
2 |
| 4 |
21251937 | Inhibition of PDGF, TGF-β, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. | 2011 Sep |
1 |
| 5 |
19047160 | Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. | 2008 Dec 1 |
1 |